P. E. Tarr

Discipline

Psychologie (4) Sociologie (2)

Type de document

Articles (23)

Co-auteur

Date

Source

Mot-clé

cohorte (16) Treatment (14) Swiss (14) Population (13) Population (12) Patients (12) Human beings (12) Patients (12) thérapie (11) risque (11) Therapeutics (11) Risk (11) virus (10) infection (10) Immunodeficiency (10) Infection (10) Older people (10) association (9) adulte (9) Methods (9) Social groups (9) Persons (9) Methods (9) adulte (9) Confidence (8) analyse (7) âge (7) Manufacturers' agents (7) Commission merchants (7) Age (7)

Documents écrit par P. E. Tarr (23) | parle de P. E. Tarr (0)

Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
F. Hovaguimian et al.
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.
J. Damas et al. (1 déc. 2021)
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
KEA Darling et al. (2021)
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
M. Metral et al.
The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
I. Locatelli et al.
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy.
C. Barceló et al.
Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study.
C. Bayard et al. (2017)
Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study.
T. Junier et al. (2016)
Strong impact of smoking on multimorbidity and cardiovascular risk among human immunodeficiency virus-infected individuals in comparison with the general population.
B. Hasse et al. (2015)
Reasons for late presentation to HIV care in Switzerland.
A. Hachfeld et al. (2015)
Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study
B. Hasse et al. (2014)
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
M. Rotger et al. (2013)
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.
M. Ortiz et al. (2011)
Antibiotiques les plus importants en ambulatoire
P.E. Tarr et al. (2011)
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.
M. Rotger et al. (2010)
Peritoneal tuberculosis after imatinib therapy.
L. Senn et al.
High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland.
T. Dang et al. (2009)
Candida arteritis in patients who have not received organ transplants: case report and review of the literature.
C. Chapuis-Taillard et al. (2008)
High prevalence of peripheral arterial disease in HIV-infected persons
D. Periard et al. (2008)
Human alveolar echinococcosis after fox population increase, Switzerland
A. Schweiger et al.
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study
A. Rauch et al.
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
P.E. Tarr et al. (2005)
Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?
J. Delaloye et al. (2004)